Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ivo Valkovsky"'
Autor:
Ivo Valkovsky, Renata Olsanska, Josef Tvrdik, Arnost Martinek, Zdenek Svagera, Marketa Pernicova, Jarmila Dedochova, Zuzana Cermakova
Publikováno v:
Biomedical Papers, Vol 159, Iss 1, Pp 093-099 (2015)
Background: Patients with chronic kidney disease (CKD) have significant disorders of bone and mineral metabolism. In addition, they can also develop other bone disorders including osteoporosis. This study evaluated the bone mineral density (BMD) of p
Externí odkaz:
https://doaj.org/article/54337ebd1c4749959efbcb1935af62da
Autor:
Vladimír Teplan, Andrea Mahrova, Jan Piťha, Jaroslav Racek, Robert Gürlich, Vladimír Teplan Jr, Ivo Valkovsky, Milena Štollova
Publikováno v:
Kidney & Blood Pressure Research, Vol 39, Iss 4, Pp 289-298 (2014)
Background/Aims: To assess, in a prospective cohort study of 238 renal transplant patients, our hypothesis that elevated ADMA levels may be influenced by physical exercise and obesity. Methods: Blood samples before and after six months were obtained
Externí odkaz:
https://doaj.org/article/50278f440da847968074563f7a9b2d37
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims IL2-RA (Interleukin 2 receptor antagonist) are recommended for the induction immunosuppression of kidney transplant recipients in patients with low/standard immunological risk. Studies showing the effectiveness of these substances
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac6438f30e4c8b5fde533ccf4d79bcf1
https://doi.org/10.1093/ndt/gfab111.0023
https://doi.org/10.1093/ndt/gfab111.0023
Publikováno v:
Journal of Renal Nutrition. 19:95-100
Successful kidney transplantation leads to restoration of renal function. Some metabolic disorders from chronic renal failure may persist and new metabolic abnormalities can develop (obesity, diabetes, hypertension, bone disease, and anemia). Additio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd307b4bfc0d36f46d7e5a8529b634a3
https://doi.org/10.1053/j.jrn.2008.10.017
https://doi.org/10.1053/j.jrn.2008.10.017
Autor:
Ivo Valkovsky, Marketa Pernicova, Jarmila Dedochova, Renata Olsanska, Zuzana Cermakova, Arnošt Martínek, Zdenek Svagera, Josef Tvrdík
Publikováno v:
Biomedical Papers, Vol 159, Iss 1, Pp 093-099 (2015)
Background: Patients with chronic kidney disease (CKD) have significant disorders of bone and mineral metabolism. In addition, they can also develop other bone disorders including osteoporosis. This study evaluated the bone mineral density (BMD) of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed84d3ea64560f2a0364d0fac9bce8f4
https://pubmed.ncbi.nlm.nih.gov/24322342
https://pubmed.ncbi.nlm.nih.gov/24322342
Autor:
Dalibor Pacík, Zdenka Krenova, Ivo Čapák, Ivo Valkovsky, Ondrej Slaby, Radek Lakomy, Leos Kren, Pavel Fabian, Jan Dolezel, Martina Rédová, Alexandr Poprach
Publikováno v:
Diagnostic Pathology, Vol 7, Iss 1, p 58 (2012)
Diagnostic Pathology
Diagnostic Pathology
Background Renal cell carcinoma (RCC) is characterized by its resistance to radiotherapy and/or chemotherapy. On the other hand, it is an immunogenic tumor - it is able to stimulate antitumor responses. A prognostic significance of HLA-G expression b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48924dad417c97747303f6626dbd3888
http://www.diagnosticpathology.org/content/7/1/58
http://www.diagnosticpathology.org/content/7/1/58
Autor:
Jarmila Dedochova, Jana Zahálková, Petr Bachleda, Karel Krejčí, Pavel Horák, Pavel Štrebl, Josef Zadrazil, Vladko Horčička, Ivo Valkovsky
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Aims: Tacrolimus and Cyclosporine A (CyA) are cornerstones in immunosuppressive therapy. Cyclosporine side eff ects include hypertension and hypercholesterolemia both of which may increase the risk of cardiovascular mortality, gingival hyperplasia an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c7955e8aed5b1eb2ba495f592d2948c
http://europepmc.org/abstract/med/19365530
http://europepmc.org/abstract/med/19365530
